Cardiology Archives - Page 50 of 78

News
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
March 12, 2019
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
News
Five pitfalls in optimizing medical management of HFrEF
March 8, 2019
SNOWMASS, COLO. – “A key message is that stability is an illusion in patients with symptomatic heart failure.” – Dr. Akshay S. Desai
News
Glyceryl trinitrate does not improve outcomes of ischemic stroke
March 7, 2019
HONOLULU – Although treatment reduced blood pressure, it did not reduce disability at 90 days, compared with sham.
News
Infective endocarditis isn’t what it used to be
March 6, 2019
Epidemiology and clinical expression of infective endocarditis are now far different from what most physicians encountered in training.
News
New SOFA version could streamline outcomes research
March 4, 2019
The eSOFA includes more objective criteria and should make it easier to compare data across institutions.
News
ICU admissions raise chronic condition risk
February 27, 2019
Compared to non-ICU visitors, patients had greater risk of developing new chronic conditions after discharge.
News
Deferoxamine does not improve 90-day outcomes after ICH
February 14, 2019
HONOLULU – The drug is safe, and data suggest that it could improve 180-day outcomes.
News
SGLT2 inhibitors morph into HF drugs
February 7, 2019
“We’re increasingly moving to an age where these agents are actually cardiovascular drugs that happen to lower blood glucose.” – Dr. Akshay S. Desai
News
Cilostazol plus aspirin or clopidogrel reduces the risk of recurrent stroke
February 7, 2019
HONOLULU – Dual therapy with cilostazol and aspirin or clopidogrel did not increase the risk of serious bleeding.
News
Intensive insulin added no benefit for hyperglycemia after ischemic stroke
February 7, 2019
Results from a large RCT showed intensive and standard insulin regimens produced similar clinical outcomes after an acute ischemic stroke.